1.
Zeineddine, N, Khoury, LE, Mosak, J. Systemic sclerosis and malignancy: a review of current data. J Clin Med Res 2016; 8(9): 625–632.
Google Scholar |
Crossref |
Medline2.
Wooten, M. Systemic sclerosis and malignancy: a review of the literature. South Med J 2008; 101(1): 59–62.
Google Scholar |
Crossref |
Medline3.
Rutherford, PA, Davison, A, Ringrose, T, et al. Rapidly progressive systemic sclerosis and acute renal failure associated with a renal cell carcinoma. Nephrol Dial Transplant 1994; 9(12): 1797–1799.
Google Scholar |
Medline4.
Nunez, S, Konstantinov, KN, Servilla, KS, et al. Association between scleroderma, renal cell carcinoma and membranous nephropathy. Clin Nephrol 2009; 71(1): 63–68.
Google Scholar |
Crossref |
Medline5.
Abrich, V, Duvuru, S, Swanson, HJ. Limited scleroderma with pauci-immune glomerulonephritis in the presence of renal cell carcinoma. Clin Med Res 2013; 11(3): 117–119.
Google Scholar |
Crossref |
Medline6.
Angulo, JC, Lopez, JI, Flores, N. Urologic malignancies and progressive systemic sclerosis. Minerva Urol Nefrol 1993; 45(1): 19–22.
Google Scholar |
Medline7.
Puett, DW, Fuchs, HA. Rapid exacerbation of scleroderma in a patient treated with interleukin 2 and lymphokine activated killer cells for renal cell carcinoma. J Rheumatol 1994; 21(4): 752–753.
Google Scholar |
Medline8.
Eisenberg, ME, Sunkureddi, PR, Baethge, BA, et al. Unusual occurrence of renal cell carcinoma (RCC) diagnosed in 2 young Hispanic patients with diffuse systemic sclerosis (dSSc). J Clin Rheumatol 2007; 13(6): 363–364.
Google Scholar |
Crossref |
Medline9.
Onishi, A, Sugiyama, D, Kumagai, S, et al. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 2013; 65(7): 1913–1921.
Google Scholar |
Crossref |
Medline10.
Shah, AA, Hummers, LK, Casciola-Rosen, L, et al. Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma. Arthritis Rheumatol 2015; 67(4): 1053–1061.
Google Scholar |
Crossref |
Medline
Comments (0)